Hyoxim 200 Tablet DT contains Cefixime 200 mg, a third-generation cephalosporin antibiotic with broad-spectrum bactericidal activity. It is indicated for the treatment of various bacterial infections caused by susceptible strains, including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible tablet (DT) for ease of administration, allowing rapid disintegration in the oral cavity without the need for water, enhancing patient compliance, especially in pediatric and geriatric populations. Hyoxim 200 is effective against both Gram-positive and Gram-negative bacteria, including Haemophilus influenzae, Escherichia coli, Klebsiella species, and Streptococcus pneumoniae. It is generally well tolerated, with common adverse effects including gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions may occur in patients with a history of penicillin or cephalosporin allergy. Dosage and duration of therapy should be guided by the severity of infection and renal function. Hyoxim 200 Tablet DT should be used under medical supervision to prevent antibiotic resistance and ensure optimal therapeutic outcomes.